Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001209191-16-132613
Filing Date
2016-07-13
Accepted
2016-07-13 17:08:13
Documents
1
Effectiveness Date
2016-07-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9271
  Complete submission text file 0001209191-16-132613.txt   10521
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-266919 | Film No.: 161766101
SIC: 2834 Pharmaceutical Preparations